嘉信理财美国中盘ETF SCHM 深 沪
等待开盘 07-17 09:30:00 美东时间
35.19
-0.190
-0.54%
华盛通- 最 高35.495
- 今 开35.10
- 成交量 100.51万股
- 最 低 35.0723
- 昨 收 35.38
- 总市值 1466.19万
- 52周最高 36.90
- 市盈率 静 --
- 换手率 241.23%
- 52周最低 27.3183
- 委 比 92.71%
- 总股本 0.00亿
- 历史最高 36.90
- 量 比 1.32
- 振 幅 1.19%
- 历史最低 6.0096
- 每 手 1
- 风险率 2.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SCHMID Group reports Q2 revenue of €27.7M; boosts full-year order targets to €125M–€150M
SCHMID Group N.V. press release (SHMD): Q2 Revenue of €27.7M. In the second quarter of 2026, the company recorded order intake of €30.7 million. Including the repeat order exceeding €37 million announ...
07-15 15:53
SCHMID Group to raise $20M through convertible notes
SCHMID Group (SHMD) said on Tuesday it agreed to raise $20M through a private placement of senior convertible notes with an institutional investor. The notes will carry a 5% annual interest rate, matu...
07-08 05:42
As corporate profit margins remain elevated, these mid-caps stand out
With U.S. corporate profit margins remaining near historic highs, investors are increasingly focused on companies that have demonstrated an ability to consistently generate strong earnings and returns...
06-18 21:25
Charles Schwab's core net new assets rise 49% Y/Y in May
Charles Schwab (SCHW) core net new assets of $49.9B jumped 49% Y/Y in May, the company said Friday in its monthly activity report. The figure rebounded more than sevenfold from $7.2B in April, which r...
06-12 21:11
Incyte Bets $1.25 Billion On Rare Bleeding Disorder Drug With Blockbuster Potential
Incyte to acquire Vega Therapeutics for $1.25 billion upfront, adding a rare bleeding disorder candidate with blockbuster potential in 2030s.
06-10 02:08
Semiconductor materials and biotech stocks drive mid‑cap YTD rally
With the market having a volatile few months, below is a list of the top 10 mid-cap stocks ranked by their Year-To-Date performance. The list includes companies from sectors such as semiconductor mate...
05-15 18:59
What's Going On With SCHMID Group Stock Thursday?
SCHMID Group stock rises 5%! Analysis of key resistance at $7.50, support at $5.50, and why the 200-day SMA keeps long-term uptrend intact.
05-15 02:31
Schmid Group Reports Preliminary Q1 Sales €18.2M And Affirms FY2026 Sales, Adjusted EBITDA And Order Intake Guidance
SCHMID Group N.V. (NASDAQ:SHMD) (the "Company" or "SCHMID"), a global leader in providing solutions to the high-tech electronics, glass, and energy systems industries, today provides an update on its operational
04-27 19:00
Most shorted mid cap stocks as of mid-April
Short sellers are concentrating their bets heavily in the mid-cap space as of mid-April. The following list ranks the 10 most heavily shorted mid-cap stocks by short interest as a percentage of float....
04-18 03:42
